Introduction
Immunofluorescence, western blots, ChIP assays and transfections are provided in the supplementary methods section.
Constructs and transfections
Fibronectin (pFN 1.2kb) and Vimentin (VimPro-1.5Kb) promoter luciferase constructs were kindly provided by Dr. Jesse Roman (Emory University) (17) and Dr. C. Gilles (Liege University, Belgium) (18) . A549 and H1650 cells were transfected using Fugene HD reagent (Roche) following manufacturer's instruction. Luciferase assays were done 48 hours post transfection, using Dual Luciferase Assay system (Promega) following the manufacturer's protocol.
siRNA transfections and Real-time PCR
For siRNA transfections 50, 75 or 100 pmol of siRNAs (Santa Cruz) with Oligofectamine were added to cells. For real-time PCR, total RNA was isolated using RNeasy miniprep kit (QIAGEN) following manufacturer's protocol, followed by first-strand cDNA synthesis using iScript cDNA synthesis kit (Bio-Rad). Data was analyzed by ''CT method, where gene of interested was normalized to 18s rRNA, then compared to the non-targeting siRNA control sample. Error bars represent the standard deviation of three independent experiments. Details of siRNAs and sequences of primers used for RT-PCR are given in supplemental methods.
Wound healing assay
A549 cells were grown in a 6-well plate (Falcon Becton Dickinson) transfected with siRNAs.
These cells were starved in serum free media for 24 hours and then washed with 1x Dulbecco's Phosphate-buffered saline (MediaTech). The cells were scratched with a sterilized 200 Pl pipette tip in three separate places in each well and medium containing 1 PM nicotine or starvation media was added to the wells. After 24 hours, the wounds were observed and images were taken in 20X magnification using Zeiss inverted phase contrast microscope. Boyden Chamber assays were used to assess the invasive ability of cells as described previously (2) . The upper surface of the 6.5 mm filters (Corning) were coated with collagen (100 µg/filter) and Matrigel (BD Bioscience) (50 µg/filter). Twenty thousand cells were plated in the upper chamber with 0.1% bovine serum albumin (Sigma). Media containing 20% fetal bovine serum was placed in the lower well as chemoattractant. The cells that invaded through the filters were quantified by counting three fields under 20X objective magnifications.
Invasion Assays
on
Statistical Methods and Analysis:
A log transformation was performed to make mRNA expression values of four genes (β arrestin1, vimentin (VIM) fibronectin (FN1) and 18SrRNA) approximately normal. Pearson rank correlation (r) was used to assess correlation among these three genes. An exact normal scores test was used to assess the association between mRNA expression values of these genes and pathological stage. The reduced monotonic regression model (19) was used to assess the association between mRNA expression values of these genes and smoking pack years. An optimal cut point for disease-free survival, defined as the time for surgical resection to disease recurrence or death, was tested for using the maximal chi-square test. All statistical analyses were performed using SAS (Version 9.2; SAS Institute; Cary, NC).
Results

β-arrestin-1 is necessary for nicotine induced disruption of tight junctions to facilitate EMT and invasion
We previously observed that nAChR stimulation results in changes reminiscent of EMT (2, 20) . To investigate the role of β-arrestin-1 in this process, A549 cells that lack β-arrestin-1 were generated by stably expressing β-arrestin-1 specific shRNA (shβ-arrestin1); cells transfected with empty vector was used as control (shcontrol). These cells were rendered quiescent by serum starvation and stimulated with 1µM nicotine, which is equivalent to the levels observed in Supplementary Fig. 1E ).
Selective knockdown of β-arrestin-1 by shRNA and siRNAs is shown in Supplementary Figure   1A -D. Similar results were observed when β-arrestin-1 was depleted by siRNA in H1650 cells (Fig. 1A, bottom panels & Supplementary Fig. 1F-G) suggesting that β-arrestin-1 is necessary for reducing tight junctions upon nAChR activation. In addition to ZO-1, the levels of E-cadherin, an epithelial marker, were significantly decreased upon nicotine stimulation only in shcontrol cells but not in shβ-arrestin1 cells ( Supplementary Fig. 2A&B ). Shcontrol cells and shβ-arrestin1 cells were grown as 3-D cultures on collagen in the presence or absence of nicotine; shcontrol cells treated with nicotine acquired a more elongated, migratory morphology, but shβ-arrestin1 cells did not show such changes (Fig. 1B) . ShE-arrestin1 cells were also impaired in their ability to migrate ( Supplementary Fig. 2C ) or invade in response to nicotine stimulation (Fig. 1C) .
Depletion of β-arrestin-1 impaired nicotine-mediated invasion of a variety of NSCLC cell lines (Fig.1D) , indicating a definite role for E-arrestin-1 in the induction of mesenchymal features in response to nAChR signaling.
β-arrestin-1 is required for the expression of vimentin and fibronectin in response to nAChR signaling
We examined whether β-arrestin-1 regulates the expression of the mesenchymal genes fibronectin and vimentin upon nAChR stimulation. Western blotting showed that nicotine treatment induced the expression of fibronectin and vimentin in shcontrol cells, but not in shβ-arrestin1 cells (Fig. 2A) ; this induction occurred at the transcriptional level (Fig. 2B) . In contrast, depletion of β-arrestin-1 did not alter TGF-β mediated vimentin or fibronectin expression,
suggesting that E-arrestin-1 plays a role in mediating EMT downstream of nAChRs. Transient transfection assays were then conducted using luciferase reporter constructs driven by human vimentin and fibronectin promoters. Shcontrol and shβ-arrestin1 cells were transfected with the reporters, rendered quiescent by serum starvation and stimulated with nicotine or TGF-β. Both promoters were induced by nicotine in shcontrol cells but not in shβ-arrestin1 cells while TGF-β could induce them in cells (Fig. 2D) . Similar pattern of induction of fibronectin and vimentin was observed when H358 cells transfected with either control siRNA or E-arrestin-1 siRNA were stimulated with nicotine or TGF-β (Fig. 2E) , showing that E-arrestin-1 plays a role in the nicotinemediated induction of these genes. Interestingly, E-arrestin-2, a closely related arrestin, did not SB431542 abrogated the induction of vimentin and fibronectin expression by TGF-E but not nicotine (Fig. 2H) , suggesting that nicotine mediated induction of these genes is independent of TGF-β. To further establish the role of β-arrestin-1 in nicotine induced EMT, we determined the levels of tight junction protein ZO1 and epithelial markers E-cadherin and β-catenin from membrane fractions of shcontrol and shβ-arrestin1 cells. As seen in Fig. 2I , nicotine treatment decreased the levels of E-cadherin, β-catenin and ZO1 in shcontrol cells, but not in shβ- Transient transfections were conducted using deletion mutants of vimentin promoter to fine map the promoter region required for E2F mediated induction ( Supplementary Fig. 5A ); it was found that the full length promoter (1.5kb; six E2F binding sites) and the deletion mutant vim-387+24 (Vim-411; three sites) could be transcriptionally induced by E2F1, but the shortest mutant vim-245+24 (Vim-269) was not E2F1 responsive ( Supplementary Fig. 5B ), suggesting that the three proximal sites were sufficient for E2F mediated transcriptional induction. Similar experiments on the deletion mutants of fibronectin promoter revealed that only a proximal binding site was necessary for induction by E2F1 ( Supplementary Fig. 5C&D ); this was confirmed by mutating this site ( Supplementary Fig. 5E ). These experiments demonstrate a direct role for E2F1 in regulating these mesenchymal promoters. Since nAChR stimulation induced the nuclear translocation of a subset of β-arrestin-1 (12), ChIP assays were conducted to determine whether it could associate with vimentin and fibronectin promoters. A549 cells were serum starved and stimulated with nicotine; quiescent cells had robust amount of Rb on these promoters. Nicotine stimulation led to an increase in the association of E2F1 and β-arrestin-1 with a concomitant dissociation of Rb from these promoters ( Fig. 3A and Supplementary Fig. S6 ). ChIP assays followed by real time PCR also showed the increased association of E2F1, β-arrestin-1, p300, and Ac-H3 with vimentin and fibronectin promoters in nicotine treated shcontrol cells, but not on shβ-arrestin1 cells. Further, Rb was present on vimentin and fibronectin promoters in shβ-arrestin1 cells even after nicotine stimulation (Fig. 3B ). An unrelated promoter, c-Fos, was used as the negative control and there was only minimal association of E2F1, Rb, β-arrestin-1, p300, and Ac-H3 on this promoter ( Supplementary Fig. S7) ; further, the fibronectin and vimentin promoters could not be detected in immunoprecipitations performed with a control irrelevant antibody (IgG), confirming the specificity of the assay. These results suggest that β-arrestin-1 mediated signaling events facilitated the dissociation of Rb and enhanced recruitment of E2F1, p300 and acetylation of histones on vimentin and fibronectin promoters.
To examine whether nicotine or TGF-β induced expression of these mesenchymal markers is dependent on E2F1, we transfected A549 cells with control siRNA or two different E2F1 siRNAs, and stimulated with nicotine or TGF-E. Western blotting (Fig. 3C&D) and RT-PCR showed that (Fig. 3E ) E2F1 was necessary for nicotine-mediated, but not TGF-E mediated, induction of vimentin and fibronectin. To assess whether β-arrestin-1 is required for the transcriptional induction of these promoters by E2F1, shcontrol and shβ-arrestin1 cells were transfected with vimentin or fibronectin promoter constructs along with E2F1. Interestingly, fibronectin and vimentin promoters were induced by E2F1 in shcontrol cells but not in shβ-arrestin1 cells ( Figure 3F&G) suggesting that E-arrestin-1 was necessary for the E2F1-mediated transcription of these genes. Experiments on control siRNA or E2F1 siRNA transfected cells also showed that E2F1 was required for the induction of vimentin and fibronectin promoters upon nicotine stimulation, but not TGF-β stimulation ( Figure 3H&I ). Collectively these results indicate that E2F1 and E-arrestin-1 are required for the nAChR mediated, but not TGFEmediated, expression of fibronectin and vimentin.
Nuclear function of β-arrestin-1 is necessary for induction of EMT
To examine whether nuclear translocation of β-arrestin-1 regulates the expression of mesenchymal genes, we performed transient transfection assays using the E-arrestin-1 mutant Q394L, in which glutamine 394 has been mutated to leucine to create a nuclear export signal (27, 28) . The mutant Q394L did not enhance E2F1 mediated transcription from fibronectin and vimentin promoters, suggesting that nuclear translocation of β-arrestin-1 is required for the transcription of these genes (Fig. 4A ).
To further explore the requirement of the nuclear function of E-arrestin-1 in inducing EMT, shβ-arrestin1 cells were transfected with pcDNA3, WT-β-arrestin1-RFP or Q394L-β-arrestin-1 constructs. Shcontrol cells transfected with pcDNA3 were used as the control. As shown in 
E2F1 -β-arrestin-1 interaction is necessary for the expression of mesenchymal genes
Previous studies from our lab had shown that amino acids 1-163 of β-arrestin-1 were required for its binding to E2F1 (Supplementary data in (12) ). We conducted IP-Western blot assays to determine if delivery of the 1-163 fragment of β-arrestin-1 disrupts the binding of endogenous We performed functional assays to explore whether binding of β-arrestin-1 to E2F1 is required for nicotine induced EMT. A549 cells were transfected with either pcDNA3 or β-arrestin-1 1-163 fragment, serum starved for 24 hours and subsequently induced with 1 µM nicotine. As seen in Figure 5D , β-arrestin-1 1-163 fragment could effectively inhibit nicotine mediated expression of vimentin and fibronectin, as well as nicotine mediated invasion ( Figure   5E ) and migration ( Figure 5F ) of cells. In conclusion, disruption of E2F1-β-arrestin-1 binding by β-arrestin-1 1-163 fragment could significantly prevent nicotine mediated mesenchymal gene expression, invasion and migration of cells.
β-arrestin-1 mediates the induction of EMT promoting transcription factors
Attempts were made to analyze the global association of β-arrestin-1 with promoters upon nicotine stimulation by ChIP-sequencing. It was found that β-arrestin-1 is recruited on the promoters of many genes that regulate EMT such as ZEB2 as well as other regulatory pathways Table 2 ; GEO accession number GSE40689). Since ZEB1 and ZEB2 are involved in the repression of epithelial genes during EMT, it was examined whether β-arrestin-1 contributes to the expression of these factors. Real-time PCR experiments showed that ZEB1 and ZEB2 are upregulated by nAChR stimulation and β-arrestin-1 was necessary for this (Supplementary Figure 9A-F) .
Since β-arrestin-1 does not possess a DNA binding domain, we hypothesized that β-arrestin-1 associates with these promoters probably through E2F1. It was found that ZEB1 had six and ZEB2 had two E2F binding sites (Supplementary Table 1 Figure 10B) . Transient transfection assays demonstrated that these promoters are indeed E2F1 responsive (Supplementary Figure 10C) .
Role of β-arrestin-1 in lung cancer metastasis
Given the above results, we examined whether E-arrestin-1 was necessary for nicotinemediated growth and metastasis of tumors in mice. ShE-arrestin1 cells showed markedly reduced ability to form tumors compared to shcontrol cells when implanted subcutaneously into athymic nude mice (Fig.6A) Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. 6B&E); shcontrol-luc tumors displayed metastases to brain, adrenal glands and liver (Fig. 6D) and nicotine treatment further enhanced metastases. Mice implanted with shβarr1-luc had significantly smaller tumors and nicotine treatment did not increase tumor growth or metastasis; ex vivo imaging of organs at the termination of the experiment confirmed these results (Fig. 6C ).
Vimentin and fibronectin expression was significantly higher in tumors from nicotine treated mice compared to vehicle treated mice implanted with shcontrol cells; tumors from mice implanted with shβ-arrestin-1 cells displayed minimal staining for vimentin and fibronectin (Fig.   6F ). The levels of β-arrestin-1 depletion in the stable β-arrestin-1 knockdown cells are shown in (29, 30) .
No significant association was observed between these gene expression patterns and pathological stages or smoking history (pack years) and disease-free survival (data not shown);
suggesting that β-arrestin-1 might be contributing to the growth and metastasis of lung cancer in both smokers and non-smokers.
ChIP assays were conducted to examine whether β-arrestin-1 is recruited to the promoters of vimentin, fibronectin, ZEB1 and ZEB2 in human lung tumors. There was enhanced association of E2F1 and β-arrestin-1 and elevated levels of acetylated histone H3 on vimentin, fibronectin, 
ZEB1 and ZEB2 promoters in tumors compared to normal lung tissues in three sets of tumor samples ( Figure 7C-E) . Taken together, these results indicate that β-arrestin-1 might have contributed to the growth and progression of NSCLCs by regulating the expression of E2F-regulated mesenchymal genes and EMT transcription factors.
Discussion
β-arrestins function as scaffold proteins that recruit a broad spectrum of signaling molecules to membrane bound receptors (11, 31) . In addition to their established roles in promoting internalization and desensitization of GPCRs, recent studies have implicated involvement of β-arrestins in Notch, frizzled, Wnt/β-catenin, nAChR signaling and regulation of gene expression by facilitating histone acetylation (32, 33) . Accumulating evidences indicate a functional role for β-arrestin-1 as a mediator of cellular migration, invasion and metastatic progression of colorectal, ovarian and breast cancer (34) (35) (36) (37) (38) (39) . In this study, we demonstrate that E-arrestin-1,
but not E-arrestin-2, plays a major role in nicotine induced EMT and metastasis, thus contributing to invasive properties of nicotine. The elevated levels of E-arrestin-1, vimentin and FN in tumors from both smokers and non-smokers demonstrate that the molecules contribute to the growth and progression of NSCLCs; at the same time, the induction of these genes could be an impoartant mechanism by which nicotine exerts its tumor promoting functions. Interestingly, E-arrestin-1 was necessary for the induction of mesenchymal promoters upon nAChR stimulation, it did not play a role in TGFE-mediated induction of these genes. The induction of these genes by E-arrestin-1 and E2F1 in response to nAChR signaling required Src activity; at the same time, TGF-E induces these mesenchymal genes through SMAD proteins suggesting a unique role for E-arrestin-1 in mediating signals downstream of nAChRs (40, 41) .
In addition, the present study demonstrates the critical role of E2F1 in regulating genes involved in EMT, including ZEB1 and ZEB2. ZEB1 suppresses the expression of basement arrestin-1 and p300 with a concomitant release of Rb; these changes were abrogated by Src inhibitors. There was no detectable level of amplification from an irrelevant antibody control IgG. 
